Violaine Mitchell

Violaine Mitchell

Director, Health Funds and Partnerships

Violaine Mitchell oversees a team that works to empower country governments to sustainably finance and manage their primary health care systems. The team fosters alignment and collaboration among a range of stakeholders, including large multilateral organizations, to strengthen health systems and expand access to lifesaving vaccines, medicines, and interventions. Violaine also represents the foundation on the governing board of Gavi, the Vaccine Alliance, whose mission is to save children’s lives by increasing access to immunization in low-income countries, and she holds leadership positions in the Global Financing Facility Investors Group.

Before joining the foundation in 2010, Violaine worked as the coordinator of the Gavi Financing Task Force under contract to the World Bank, where she was responsible for coordinating the vaccine alliance’s early work on national financial sustainability planning and global innovative financing. Earlier, she worked at the Institute of Medicine (IOM), National Academy of Sciences, where she was the study director for a study on the Children’s Vaccine Initiative and assistant study director for the IOM Study on Malaria Prevention and Control. Violaine has a B.A. in development studies from Brown University and an M.S. in tropical public health from the Harvard School of Public Health.

See articles by Violaine Mitchell

GIF highlight COVID-19 data

During COVID-19, women’s health care must be an essential service: A conversation with three experts

Three experts on women's health care in low- and middle-income countries discuss maintaining services during the pandemic.
By Lester Coutinho, Jeffrey Smith, and Violaine Mitchell

Ending wild polio in Africa: A Q&A with Michael Galway and Violaine Mitchell

The foundation’s Michael Galway and Violaine Mitchell discuss the efforts behind Africa’s wild polio-free status and what it means for the future.
By Michael Galway and Violaine Mitchell

Looking back on vaccines in 2018

Some of the most significant breakthroughs in 2018 came in the field of vaccine development and delivery, where we again saw progress on immunization. Today, more people in the poorest parts of the world, especially children, are getting protected against infectious diseases, while new innovations are producing vaccines more cheaply and getting them to the communities who need them more effectively.
By Michael Lea Senior Writer, Bill & Melinda Gates Foundation

More about the foundation

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we've created to address urgent issues in global health, global development, and education.


Read the latest stories, research, and news from across the foundation and subscribe to our weekly newsletter, The Optimist.